Hospital
Phc-Cleveland LLC
Phc-Cleveland LLC was paid $23.43M by Medicaid between Jan 2018 and Dec 2024, across 223 billing codes. Its largest line is 99284, emergency room visit (serious) — 20% of everything it billed.
33Billing provider infoPHC-CLEVELAND LLC
CLEVELAND, MS 38732
CLEVELAND, MS 38732
33aNPI1457321036assigned 01/25/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$23.43M
24GClaims617,345
24DCodes billed223
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Mississippi
Rank by total paid#22 of 77
Median peer was paid$8.23M
This provider vs. median2.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official TRAYLOR, JOHNETTA controls 20+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 116,721 | $4.81M | |
| 2019 | 106,731 | $4.29M | |
| 2020 | 74,829 | $2.75M | |
| 2021 | 88,580 | $3.07M | |
| 2022 | 94,118 | $3.01M | |
| 2023 | 76,108 | $3.16M | |
| 2024incomplete | 60,258 | $2.35M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 20% | 26,698 | 21,181 | $4.67M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 12% | 21,967 | 17,771 | $2.92M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 9.8% | 11,935 | 9,326 | $2.29M |
| 92507 | Treatment of speech, language, voice, communication, and/or auditory processing disorder | 5.1% | 21,939 | 4,770 | $1.19M |
| G0378 | Hospital observation service, per hour | 4.8% | 2,986 | 2,026 | $1.13M |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 2.9% | 16,941 | 13,564 | $679K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 2.6% | 17,805 | 3,244 | $620K |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | 2.6% | 17,384 | 3,572 | $602K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.6% | 7,498 | 5,985 | $600K |
| 71045 | Radiologic examination, chest; single view | 2.3% | 15,344 | 11,747 | $532K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 2.0% | 4,845 | 3,244 | $479K |
| 59025 | Fetal non-stress test | 2.0% | 4,557 | 2,292 | $458K |
211 more codes
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.8% | 5,521 | $427K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 1.8% | 2,451 | $413K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.6% | 7,005 | $386K |
| 37229 | 1.3% | 189 | $316K | |
| 54161 | 1.3% | 270 | $297K | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | 1.2% | 3,158 | $286K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1.2% | 15,371 | $280K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.2% | 3,312 | $271K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.0% | 7,621 | $237K |
| D2930 | Prefabricated stainless steel crown - primary tooth | <1% | 1,570 | $218K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 5,171 | $212K |
| D7140 | Extraction, erupted tooth or exposed root | <1% | 730 | $208K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 40,135 | $199K |
| 80053 | Comprehensive metabolic panel | <1% | 28,539 | $195K |
| 41899 | Unlisted procedure, dentoalveolar structures | <1% | 1,499 | $177K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 4,126 | $159K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 1,318 | $157K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 6,076 | $138K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 1,353 | $137K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 9,825 | $135K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 4,333 | $132K |
| 86900 | <1% | 2,233 | $111K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 8,850 | $108K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 3,560 | $101K |
| 86710 | <1% | 8,867 | $99K | |
| 83880 | <1% | 4,897 | $95K | |
| 87430 | <1% | 7,067 | $89K | |
| 84484 | <1% | 9,707 | $68K | |
| 87040 | <1% | 7,591 | $60K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 9,406 | $59K |
| 37225 | <1% | 48 | $58K | |
| 74018 | <1% | 1,308 | $57K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 1,152 | $49K |
| 36415 | Collection of venous blood by venipuncture | <1% | 23,341 | $49K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 613 | $49K |
| 86850 | <1% | 2,041 | $48K | |
| D3220 | Therapeutic pulpotomy (excluding final restoration) - removal of pulp coronal to the dentinocemental junction | <1% | 816 | $41K |
| 36600 | <1% | 903 | $38K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 1,384 | $38K |
| 70486 | <1% | 510 | $35K | |
| 73560 | <1% | 1,030 | $34K | |
| 86901 | <1% | 2,228 | $34K | |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 556 | $34K |
| 84703 | <1% | 6,096 | $33K | |
| 87420 | <1% | 2,779 | $30K | |
| 87186 | <1% | 4,631 | $30K | |
| 97533 | <1% | 814 | $30K | |
| 81003 | <1% | 19,946 | $29K | |
| D0350 | <1% | 1,232 | $26K | |
| 97162 | <1% | 633 | $26K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 5,559 | $24K |
| 71250 | <1% | 585 | $23K | |
| 93970 | <1% | 328 | $22K | |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 774 | $22K |
| 73630 | <1% | 608 | $22K | |
| J1610 | Injection, glucagon hydrochloride, per 1 mg | <1% | 470 | $21K |
| 82553 | <1% | 2,372 | $21K | |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | <1% | 16 | $19K |
| 92523 | <1% | 147 | $19K | |
| 83690 | <1% | 4,495 | $19K | |
| 87070 | <1% | 2,585 | $19K | |
| 85379 | <1% | 3,388 | $19K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 2,837 | $18K |
| 83735 | <1% | 5,363 | $18K | |
| 87075 | <1% | 2,044 | $17K | |
| 82962 | <1% | 8,343 | $16K | |
| 84702 | <1% | 1,504 | $16K | |
| 73130 | <1% | 345 | $15K | |
| 11043 | <1% | 88 | $15K | |
| 82150 | <1% | 3,146 | $14K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 188 | $14K |
| 87088 | <1% | 1,753 | $14K | |
| D0140 | Limited oral evaluation - problem focused | <1% | 1,330 | $13K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,286 | $13K |
| 36430 | <1% | 141 | $12K | |
| 82803 | <1% | 955 | $12K | |
| 85730 | <1% | 3,845 | $12K | |
| 73030 | <1% | 305 | $11K | |
| 97010 | <1% | 3,914 | $11K | |
| 83605 | <1% | 1,724 | $11K | |
| 73610 | <1% | 243 | $11K | |
| D2330 | <1% | 751 | $10K | |
| 82550 | <1% | 1,882 | $10K | |
| 80061 | Lipid panel | <1% | 846 | $10K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 180 | $10K |
| 72100 | <1% | 211 | $9K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 35 | $9K |
| 74022 | <1% | 129 | $9K | |
| 85610 | <1% | 3,897 | $9K | |
| 86140 | <1% | 2,047 | $8K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 95 | $8K |
| 86920 | <1% | 164 | $7K | |
| 86921 | <1% | 162 | $7K | |
| P9016 | Red blood cells, leukocytes reduced, each unit | <1% | 86 | $6K |
| 72131 | <1% | 129 | $6K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 188 | $6K |
| D1206 | Topical application of fluoride varnish | <1% | 753 | $5K |
| 76770 | <1% | 175 | $5K | |
| 83655 | <1% | 373 | $5K | |
| 97113 | <1% | 95 | $5K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 5,164 | $4K |
| 83615 | <1% | 915 | $4K | |
| 83721 | <1% | 849 | $3K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 180 | $3K |
| 97161 | <1% | 72 | $3K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 9,400 | $3K |
| 76801 | <1% | 53 | $3K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 129 | $3K |
| C1894 | Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser | <1% | 276 | $3K |
| C1760 | Closure device, vascular (implantable/insertable) | <1% | 339 | $3K |
| 86922 | <1% | 78 | $3K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 37 | $3K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 227 | $3K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 461 | $2K |
| 92651 | <1% | 23 | $2K | |
| 80305 | <1% | 301 | $2K | |
| 96376 | <1% | 951 | $2K | |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 33 | $2K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 23 | $2K |
| 97597 | <1% | 19 | $2K | |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 48 | $2K |
| 73110 | <1% | 31 | $2K | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 10,301 | $2K |
| 73502 | <1% | 46 | $1K | |
| 93925 | <1% | 17 | $1K | |
| 73590 | <1% | 33 | $1K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,773 | $1K |
| 82728 | <1% | 162 | $1K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 15 | $1K |
| 77065 | Tomosynthesis, mammo | <1% | 28 | $997.19 |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 12 | $947.47 |
| 82607 | <1% | 79 | $929.41 | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 23 | $872.99 |
| 93922 | <1% | 18 | $745.64 | |
| 84550 | <1% | 168 | $602.97 | |
| G0283 | Electrical stimulation (unattended), to one or more areas for indication(s) other than wound care, as part of a therapy plan of care | <1% | 48 | $536.75 |
| 77066 | Tomosynthesis, mammo | <1% | 12 | $527.86 |
| 76642 | <1% | 12 | $492.75 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 6,415 | $454.31 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 3,668 | $437.34 |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,163 | $434.19 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 9,524 | $411.97 |
| 85651 | <1% | 108 | $344.94 | |
| 82270 | <1% | 125 | $331.77 | |
| 84153 | <1% | 50 | $311.36 | |
| A9270 | Non-covered item or service | <1% | 5,387 | $280.05 |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 1,774 | $279.70 |
| 84156 | <1% | 155 | $260.58 | |
| D1351 | Sealant - per tooth | <1% | 52 | $256.16 |
| 82565 | <1% | 62 | $245.27 | |
| 97116 | <1% | 35 | $206.48 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 1,315 | $178.56 |
| 80076 | <1% | 20 | $156.94 | |
| 97535 | Self-care/home management training, each 15 minutes | <1% | 269 | $149.98 |
| 85045 | <1% | 44 | $146.61 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 3,660 | $144.91 |
| 82570 | <1% | 59 | $114.53 | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 847 | $83.72 |
| J7510 | Prednisolone oral, per 5 mg | <1% | 897 | $65.19 |
| 83540 | <1% | 24 | $64.02 | |
| 82247 | <1% | 15 | $63.55 | |
| 82248 | <1% | 15 | $63.55 | |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 1,180 | $59.23 |
| 85014 | <1% | 31 | $54.33 | |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 5,441 | $53.32 |
| 82009 | <1% | 17 | $40.70 | |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 2,654 | $40.63 |
| J1815 | Injection, insulin, per 5 units | <1% | 399 | $35.25 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 1,133 | $31.14 |
| 85018 | <1% | 14 | $27.93 | |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 204 | $27.91 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 887 | $23.44 |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 398 | $20.88 |
| J1650 | Injection, enoxaparin sodium, 10 mg | <1% | 410 | $17.23 |
| P9612 | Catheterization for collection of specimen, single patient, all places of service | <1% | 43 | $0.37 |
| C1724 | Catheter, transluminal atherectomy, rotational | 0% | 183 | $0.00 |
| C9113 | Injection, pantoprazole sodium, per vial | 0% | 95 | $0.00 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 0% | 88 | $0.00 |
| 76937 | 0% | 315 | $0.00 | |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 175 | $0.00 |
| 90715 | 0% | 127 | $0.00 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 363 | $0.00 |
| C1887 | Catheter, guiding (may include infusion/perfusion capability) | 0% | 237 | $0.00 |
| J3370 | Injection, vancomycin hcl, 500 mg | 0% | 21 | $0.00 |
| C1885 | Catheter, transluminal angioplasty, laser | 0% | 12 | $0.00 |
| J2274 | Injection, morphine sulfate, preservative-free for epidural or intrathecal use, 10 mg | 0% | 18 | $0.00 |
| C1725 | Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) | 0% | 149 | $0.00 |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 1,760 | $0.00 |
| J0360 | Injection, hydralazine hcl, up to 20 mg | 0% | 820 | $0.00 |
| C1769 | Guide wire | 0% | 403 | $0.00 |
| G0379 | Direct admission of patient for hospital observation care | 0% | 17 | $0.00 |
| J1940 | Injection, furosemide, up to 20 mg | 0% | 550 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 2,828 | $0.00 |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 0% | 345 | $0.00 |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | 0% | 118 | $0.00 |
| C1726 | Catheter, balloon dilatation, non-vascular | 0% | 195 | $0.00 |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 125 | $0.00 |
| 37233 | 0% | 50 | $0.00 | |
| C1893 | Introducer/sheath, guiding, intracardiac electrophysiological, fixed-curve, other than peel-away | 0% | 15 | $0.00 |
| J2060 | Injection, lorazepam, 2 mg | 0% | 151 | $0.00 |
| 96368 | 0% | 22 | $0.00 | |
| J3480 | Injection, potassium chloride, per 2 meq | 0% | 258 | $0.00 |
| 77063 | Screening digital breast tomosynthesis, bilateral | 0% | 65 | $0.00 |
| J2175 | Injection, meperidine hydrochloride, per 100 mg | 0% | 121 | $0.00 |
| C2623 | Catheter, transluminal angioplasty, drug-coated, non-laser | 0% | 72 | $0.00 |
| C1733 | Catheter, electrophysiology, diagnostic/ablation, other than 3d or vector mapping, other than cool-tip | 0% | 32 | $0.00 |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | 0% | 33 | $0.00 |
| J0461 | Injection, atropine sulfate, 0.01 mg | 0% | 56 | $0.00 |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | 0% | 49 | $0.00 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 0% | 14 | $0.00 |
| 99406 | 0% | 23 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialTRAYLOR, JOHNETTA (DIRECTOR)
| Provider | Location | Paid |
|---|---|---|
| Logan General Hospital LLC | Logan, WV | $43.43M |
| Hartsville, LLC | Hartsville, SC | $18.42M |
| Logan Memorial Hospital LLC | Russellville, KY | $14.29M |
| Southwestern Medical Center, LLC | Lawton, OK | $9.40M |
| Palestine Principal Healthcare Limited Partnership | Palestine, TX | $6.80M |
| Watertown Medical Center LLC | Watertown, WI | $6.31M |
| Amg - Livingston, LLC | Livingston, TN | $5.52M |
| Logan General Hospital LLC | Logan, WV | $4.91M |
| ST. Joseph Hospital LLC | Lewiston, ID | $4.67M |
| Riverton Memorial Hospital LLC | Riverton, WY | $4.65M |
| Livingston Regional Hospital LLC | Livingston, TN | $4.33M |
| Hartsville Medical Group LLC | Hartsville, SC | $4.16M |
| Mexia Principal Healthcare Limited Partnership | Mexia, TX | $2.19M |
| Palestine Principal Healthcare Limited Partnership | Palestine, TX | $1.27M |
| Texas Specialty Physicians | Palestine, TX | $1.26M |
| ST Joseph Hospital LLC | Lewiston, ID | $1.10M |
| Watertown Physician Practices LLC | Watertown, WI | $244K |
| Watertown Physician Practices LLC | Watertown, WI | $175K |
| Amg-Livingston LLC | Livingston, TN | $165K |
| Watertown Physician Practices LLC | Watertown, WI | $149K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.